Chemomab Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.6%.

Top 24 shareholders own 37.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.8%	OrbiMed Advisors LLC	2,241,274	US$1.8m	0%	0.03%
7.8%	Peter Thiel	1,108,509	US$902.3k	0%	no data
5.12%	Presight Capital	727,163	US$591.9k	0%	2.27%
4%	Adi George	568,222	US$462.5k	-2.37%	no data
1.5%	Ikarian Capital, LLC	213,392	US$173.7k	0%	0.04%
1.06%	Neil Cohen	151,218	US$123.1k	1,410%	no data
0.5%	Morgan Stanley, Investment Banking and Brokerage Investments	70,915	US$57.7k	0%	no data
0.4%	Two Sigma Investments, LP	56,305	US$45.8k	0%	no data
0.25%	Two Sigma Advisers, LP	35,400	US$28.8k	0%	no data
0.23%	Citadel Advisors LLC	32,677	US$26.6k	0%	no data
0.22%	Kestra Private Wealth Services, LLC	31,241	US$25.4k	0%	no data
0.2%	XTX Holdings Limited, Asset Management Arm	29,047	US$23.6k	0%	0.01%
0.19%	Boothbay Fund Management, LLC	26,529	US$21.6k	0%	no data
0.18%	Virtu Financial LLC, Asset Management Arm	25,808	US$21.0k	0%	no data
0.14%	Millennium Management LLC	19,701	US$16.0k	0%	no data
0.13%	Rhumbline Advisers Ltd Partnership	18,627	US$15.2k	0%	no data
0.11%	Sigal Fattal	15,002	US$12.2k	188%	no data
0.083%	Geode Capital Management, LLC	11,737	US$9.6k	0%	no data
0.081%	Susquehanna International Group, LLP, Asset Management Arm	11,477	US$9.3k	0%	no data
0.0084%	Nissim Darvish	1,200	US$977.0	0%	no data
0.0035%	Moser Wealth Advisors, LLC	500	US$407.0	0%	no data
0.0007%	Blackstone Alternative Investment Advisors LLC	100	US$80.9	0%	no data
0.00031%	Qube Research & Technologies Ltd	44	US$35.8	0%	no data
0.00001%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	US$1.2	0%	no data